tiprankstipranks
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market
ACRS
Aclaris Therapeutics
RESEARCH TOOLSreports
Want to see ACRS full AI Analyst Report?

Aclaris Therapeutics (ACRS) Income Statement

920 Followers

Aclaris Therapeutics Income Statement

Last quarter (Q1 2026), Aclaris Therapeutics's total revenue was $2.00M, an increase of 37.18% from the same quarter last year. In Q1, Aclaris Therapeutics's net income was $-19.82M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.83M$ 18.72M$ 31.25M$ 29.75M$ 6.76M
Gross Profit
$ 5.74M$ 15.93M$ 13.17M$ 17.79M$ 2.05M
Operating Expenses
$ 82.11M$ 157.86M$ 110.53M$ 107.65M$ 91.77M
Depreciation and Amortization
$ 454.00K$ 807.00K$ 863.00K$ 797.00K$ 923.00K
EBITDA
$ -64.47M$ -51.72M$ -115.45M$ -84.36M$ -64.46M
Operating Income
$ -76.38M$ -141.93M$ -97.36M$ -89.85M$ -89.72M
Other Income/Expenses
$ 11.45M$ 9.87M$ 8.51M$ 2.95M$ -1.14M
Pretax Income
$ -64.92M$ -132.06M$ -88.85M$ -86.91M$ -90.86M
Net Income
$ -64.92M$ -132.06M$ -88.48M$ -86.91M$ -90.86M
Per Share Metrics
Basic EPS
$ -0.53$ -1.71$ -1.27$ -1.33$ -1.60
Diluted EPS
$ -0.53$ -1.71$ -1.27$ -1.33$ -1.60
Weighted Average Shares Outstanding
 122.66M 77.30M 69.81M 65.21M 56.73M
Weighted Average Shares Outstanding (Diluted)
 122.66M 77.30M 69.81M 65.21M 56.73M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History